[go: up one dir, main page]

PL2205623T3 - Ochronne tetrapeptydy do pielęgnacji skóry - Google Patents

Ochronne tetrapeptydy do pielęgnacji skóry

Info

Publication number
PL2205623T3
PL2205623T3 PL08844747.9T PL08844747T PL2205623T3 PL 2205623 T3 PL2205623 T3 PL 2205623T3 PL 08844747 T PL08844747 T PL 08844747T PL 2205623 T3 PL2205623 T3 PL 2205623T3
Authority
PL
Poland
Prior art keywords
tetrapeptides
skin care
protective skin
protective
care
Prior art date
Application number
PL08844747.9T
Other languages
English (en)
Inventor
Lijuan Zhang
Scott M. Harris
Timothy J. Falla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2205623T3 publication Critical patent/PL2205623T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL08844747.9T 2007-10-29 2008-10-28 Ochronne tetrapeptydy do pielęgnacji skóry PL2205623T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81507P 2007-10-29 2007-10-29

Publications (1)

Publication Number Publication Date
PL2205623T3 true PL2205623T3 (pl) 2016-09-30

Family

ID=40305326

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08844747.9T PL2205623T3 (pl) 2007-10-29 2008-10-28 Ochronne tetrapeptydy do pielęgnacji skóry

Country Status (9)

Country Link
US (1) US8071555B2 (pl)
EP (1) EP2205623B1 (pl)
JP (1) JP5379806B2 (pl)
KR (1) KR101668803B1 (pl)
CN (1) CN101855235B (pl)
CA (1) CA2701420C (pl)
ES (1) ES2567706T3 (pl)
PL (1) PL2205623T3 (pl)
WO (1) WO2009058244A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2438962A3 (en) 2006-02-13 2012-07-18 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
KR102425466B1 (ko) 2011-06-24 2022-07-25 노노 인코포레이티드 허혈에 대한 psd-95 억제제와의 조합 요법
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
KR102113998B1 (ko) * 2012-04-16 2020-05-25 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 피부 및／또는 점막의 치료 및／또는 관리용 화합물 및 미용적 또는 약학적 조성물에서의 이의 용도
KR20150036274A (ko) 2012-07-19 2015-04-07 알레시아 바이오쎄라퓨틱스 인코포레이티드 항-siglec-15 항체
US10195245B2 (en) * 2013-06-14 2019-02-05 Helix Biomedix, Inc. Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
US9636292B2 (en) 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
US9351911B1 (en) 2015-07-30 2016-05-31 Truth Aesthetics LLC Topical skin care composition providing broad spectrum sunscreen
CN107629111B (zh) * 2017-10-26 2021-06-04 陕西慧康生物科技有限责任公司 一种乙酰基四肽-2的液相合成方法
WO2020107079A1 (en) * 2018-11-30 2020-06-04 Interk Peptide Therapeutics Limited Polypeptides and methods for improving skin conditions
KR102120992B1 (ko) * 2019-05-03 2020-06-10 (주)위바이오트리 신규한 금속 층상수산화물 복합체 및 이의 제조방법
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
KR102778423B1 (ko) * 2019-09-26 2025-03-10 (주)아모레퍼시픽 피부 각질세포의 항노화 물질 스크리닝 방법, 스크리닝 키트 및 피부 각질세포의 항노화 물질 함유 조성물
EP4001294A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
FR3123193B1 (fr) * 2021-05-28 2025-11-07 Oreal Procédé d’électroporation pour délivrer une composition comprenant au moins un peptide de poids moléculaire allant de 500 Da à 20 kDa
US20250268807A1 (en) * 2022-04-27 2025-08-28 Sbla Brands Inc. Anti-aging peptide containing cosmetic

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357122A (en) 1970-07-28 1974-06-19 Squibb & Sons Inc Polypeptide intermediates
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DE68918388T2 (de) 1988-04-21 1995-03-02 Uab Research Foundation Bioelastomer ohne adhäsionseigenschaft zum einsatz am wundort.
AU5433190A (en) 1989-04-10 1990-11-16 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5464820A (en) * 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
US6143742A (en) * 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
IL138594A0 (en) * 1998-04-01 2001-10-31 Biotech Australia Pty Ltd Use of protease inhibitors for treating skin wounds
CA2312075A1 (en) * 1998-11-05 2001-12-22 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
US6096327A (en) * 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6284802B1 (en) * 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
CA2441562C (en) 2001-03-28 2013-05-14 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
US6998383B2 (en) 2001-05-11 2006-02-14 Research Development Corporation Inhibitors of receptor activator of NF-κB and uses thereof
US20040167072A1 (en) * 2001-05-11 2004-08-26 Aggarwal Bharat B. Inhibitors of receptor activator of NF-kappaB and uses thereof
US7238656B2 (en) * 2001-08-29 2007-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
JP2005519587A (ja) * 2001-11-28 2005-07-07 ベクトン・ディキンソン・アンド・カンパニー 増殖阻害作用を有するペプチド
AU2003225540A1 (en) * 2002-01-31 2003-09-02 Irm, Llc Hepsin substrates and prodrugs
EP1504033A2 (en) * 2002-05-03 2005-02-09 Millenium Biologix Inc. Connective tissue stimulating peptides
US7265097B2 (en) * 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
CN1893911B (zh) * 2003-11-17 2010-12-29 赛德玛公司 含有四肽和三肽混合物的配方
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
US7271239B2 (en) * 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
US20060046271A1 (en) * 2004-09-02 2006-03-02 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
CA2614084A1 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
US20070077305A1 (en) * 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) * 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
EP2024538B1 (en) 2006-02-21 2012-11-14 President and Fellows of Harvard College Chlamydia polypeptide

Also Published As

Publication number Publication date
JP5379806B2 (ja) 2013-12-25
KR20100083828A (ko) 2010-07-22
EP2205623A1 (en) 2010-07-14
WO2009058244A1 (en) 2009-05-07
HK1146070A1 (zh) 2011-05-13
US20090142280A1 (en) 2009-06-04
CA2701420A1 (en) 2009-05-07
US8071555B2 (en) 2011-12-06
EP2205623B1 (en) 2016-03-16
KR101668803B1 (ko) 2016-10-24
CN101855235B (zh) 2013-04-24
CN101855235A (zh) 2010-10-06
CA2701420C (en) 2016-02-09
ES2567706T3 (es) 2016-04-26
JP2011502121A (ja) 2011-01-20

Similar Documents

Publication Publication Date Title
PL2205623T3 (pl) Ochronne tetrapeptydy do pielęgnacji skóry
TWI348920B (en) Whitening agent and skin care agent
PL2278952T3 (pl) Środki do czyszczenia skóry i rąk
ZA201006941B (en) Compositions and methods for skin care
EP2168568A4 (en) SKIN COSMETICS
PL2200577T3 (pl) Kompozycja do pielęgnacji włosów
EP2233154A4 (en) EXTERNAL SKIN PREPARATION
GB0708938D0 (en) Skin care composition
PH12010000395A1 (en) Mild leave-on skin care compositions
GB0716605D0 (en) Skin antiseptics
PT2200624T (pt) Bagas de góji e inflamação da pele
EP2221046A4 (en) SKIN CARE PREPARATIONS
EP2104442A4 (en) COSMETIC HOUSING
GB0719202D0 (en) Compositions and methods for the skin and hair
GB0722974D0 (en) Skin sensor device
DE602008002077D1 (de) Hautpflegevorrichtung
GB0702931D0 (en) Skin application
EP2164446A4 (en) HIGH-FOAMING CLEANSING COMPOSITION WITH SKIN CARE PRODUCT
EP2165699A4 (en) CAPILLARY COSMETICS
EP2042153A4 (en) skin cosmetic
GB0606921D0 (en) Skin dressing
EP2156820A4 (en) SKIN WHITENING AGENT
HUP0800340D0 (en) Device for skin care with light-therapy
TWI371289B (en) Mixture for skin care
AU317383S (en) Cosmetic device